In ₹ Crore except Per Share Latest Annual | RPGLIFE FY26 | GUFICBIO FY26 | GUJTHEM FY26 | UNICHEMLAB FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 153.76× | 66.84× | — | ◆ 14.76× | 40.80× +277% | |
| P/B | 7.59× | 6.45× | 16.28× | ◆ 1.37× | 6.45× +18% | |
| EV/EBITDA | 29.80× | 30.48× | 64.11× | ◆ 21.23× | 30.48× -2% | |
| Market Cap | ₹4,597 Cr | ₹4,290 Cr | ₹4,685 Cr | ₹3,731 Cr | ₹4,290 Cr +7% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | — | — | 17.91% | 17.91% | |
| Revenue CAGR 5Y | — | — | — | 12.26% | 12.26% | |
| Revenue YoY (latest Q) | — | 16.58% | ◆ 22.07% | 20.13% | 20.13% | |
| Net Income YoY (latest Q) | — | 70.71% | 22.12% | ◆ 496.08% | 70.71% | |
| Profitability | ||||||
| EBITDA Margin | 20.79% | 16.03% | ◆ 45.55% | 8.36% | 16.03% +30% | |
| Net Income Margin | 16.28% | 6.80% | ◆ 28.15% | 11.48% | 11.48% +42% | |
| Return on Common Equity | ◆ 19.02% | 9.66% | 16.22% | 9.30% | 9.66% +97% | |
| Return on Capital Employed | ◆ 19.86% | 14.61% | 14.76% | 2.07% | 14.61% +36% | |
| Return on Assets | ◆ 14.52% | 4.78% | 9.27% | 6.77% | 6.77% +114% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.03× | 0.58× | 0.56× | 0.17× | 0.56× -95% | |
| Interest Coverage | ◆ 141.13× | 3.29× | 21.23× | 1.87× | 3.29× +4190% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹708 Cr | ₹944 Cr | ₹166 Cr | ₹2,202 Cr | ₹944 Cr -25% | |
| Net Income | ₹115 Cr | ₹64.2 Cr | ₹46.7 Cr | ₹253 Cr | ₹64.2 Cr +79% | |
| Total Assets | ₹793 Cr | ₹1,342 Cr | ₹503 Cr | ₹3,737 Cr | ₹1,342 Cr -41% | |
| EPS | ₹18.08 | ₹6.4 | ₹0 | ₹35.91 | ₹6.4 +182% | |
| Book Value per Share | ₹366.07 | ₹66.31 | ₹26.41 | ₹386 | ₹66.31 +452% | |